Peer-influenced content. Sources you trust. No registration required. This is HCN.

Cleveland Clinic Journal of MedicineACE Inhibitor and ARB Therapy: Practical Recommendations

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are cornerstones of cardiovascular disease therapy. In this article (registration required) from the Cleveland Clinic Journal of Medicine, the author provides insight and commentary on whether ACE inhibitors are better than ARBs. The conclusion is there is more to the story and the evidence than you may think.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form